Harvey Investment Company’s Allergan plc AGN Stock Holding History

Harvey Investment Company’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,502	Closed	-$851K	–	83
2017 Q2	$851K	Sell	3,502 -1,277	-27%	-$300K	0.17%	57
2017 Q1	$1.14M	Sell	4,779 -2,890	-38%	-$673K	0.24%	53
2016 Q4	$1.61M	Sell	7,669 -6,242	-45%	-$1.29M	0.34%	48
2016 Q3	$3.2M	Sell	13,911 -1,820	-12%	-$445K	0.68%	38
2016 Q2	$3.63M	Sell	15,731 -1,139	-7%	-$263K	0.79%	37
2016 Q1	$4.52M	Sell	16,870 -4,235	-20%	-$1.21M	1%	30
2015 Q4	$6.59M	Sell	21,105 -4,474	-17%	-$1.33M	1.51%	27
2015 Q3	$6.95M	Sell	25,579 -956	-4%	-$294K	1.68%	24
2015 Q2	$8.05M	Sell	26,535 -2,205	-8%	-$658K	1.87%	24
2015 Q1	$8.55M	Buy	+28,740	New	+$8.19M	2.03%	20

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Harvey Investment Company's AGN Position: Q3 2017 in Review

Harvey Investment Company sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 3,502 shares — an estimated $851K sold.

Harvey Investment Company first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $8.55M in Q1 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Harvey Investment Company reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
Harvey Investment Company sold 3,502 Allergan plc shares in Q3 2017, an estimated $851K.
Harvey Investment Company first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
Harvey Investment Company's Allergan plc position peaked at $8.55M in Q1 2015.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Harvey Investment Company's 13F filing for Q3 2017, filed 18 Oct 2017.